People: Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)
15.12CNY
17 May 2013
¥-0.02 (-0.13%)
¥15.14
¥15.13
¥15.18
¥14.89
6,179,236
8,532,127
¥17.95
¥13.14
Bao, Rusheng
Brief Biography
Mr. Bao Rusheng has been serving as Senior Vice President and Director in Zhejiang Hisun Pharmaceutical Co., Ltd. since April 24, 2013. He also serves as Chairman of the Board and Director in other three companies. He served as Assistant General Manager in the Company.
Basic Compensation
| Total Annual Compensation, CNY | Long-Term Incentive Plans, CNY | All Other, CNY | Fiscal Year Total, CNY |
|---|---|---|---|
| -- | -- | -- | 463,000 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Hua Bai |
1,749,000 |
Guoqing Lou |
-- |
Lingli Wei |
257,000 |
Rusheng Bao |
463,000 |
Jianqiu Lin |
439,000 |
Haibin Wang |
393,000 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
